10-Q quarterly report · filed Nov 5, 2026

Nutex Health Inc. (NUTX) Q3 2026 10-Q Quarterly Report

Short answer

Nutex Health Inc. (NUTX) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $218M (down 18.7% year over year) with net income of $40M.

Q3 2026 key financials · XBRL

Revenue
$218M
−18.7% YoY · +3.3% QoQ
Net income
$40M
−27.4% YoY · −38.9% QoQ
Operating margin
35.4%
Gross margin
46.7%
EPS (diluted)
$5.63
−32.3% YoY · −39.8% QoQ

Source: XBRL data from the Nutex Health Inc. (NUTX) Q3 2026 10-Q on SEC EDGAR. USD.

Nutex Health Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $217.6M, down $50.2M YoY from $267.8M, driven by hospital revenue decline
  • Operating margin 35.4% vs 48.7% YoY, net income margin 26.4% vs 36.1%
  • Best segment: population health revenue $8.5M vs $7.6M; worst: hospital revenue $209.1M vs $260.2M
  • Cash $249.9M vs $185.6M at December 31, 2025; operating cash flow $188.1M
  • Headwinds: IDR volatility, regulatory changes, cybersecurity incident, uncertain enforcement of unpaid awards

Risk Factors

  • Cybersecurity incident: August 2026 unauthorized access and exfiltration of patient, employee, provider, business and financial data
  • Legal exposure: putative class actions filed in Southern District of Texas over alleged inadequate security measures
  • Regulatory compliance: HIPAA, Texas privacy laws, Senate Bill 1188 and SEC cybersecurity rules create evolving obligations
  • Operational risk: third-party technology failures could disrupt systems and expose sensitive information
  • Financial risk: remediation costs and liabilities may exceed insurance coverage

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Nutex Health Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.